XML 437 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Balance Sheets (Parenthetical) - EUR (€)
€ in Millions
Dec. 31, 2025
Dec. 31, 2024
Common stock, shares, outstanding (in shares) 385,417,665 393,283,720
Accounts receivable, net [1] € 3,023.0 € 4,477.5
Loans receivable [2] 266.1 0.0
Loans receivable, noncurrent [3] 1,653.9 1,456.6
Other assets [4] 1,432.8 1,940.3
Other non-current assets  [5] 1,057.1 790.8
Accounts payable [6] 3,521.8 3,500.4
Related party    
Accounts receivable, net 1.1 70.8
Loans receivable [2] 260.2 0.0
Loans receivable, noncurrent 1,647.3 1,440.8
Other assets 323.5 815.8
Other non-current assets  868.4 599.9
Accounts payable 1,085.8 955.8
Accrued and other liabilities € 123.0 € 199.9
Common stock    
Ordinary shares, nominal value (in EUR per share) € 0.09 € 0.09
Ordinary Shares, authorized (in shares) 700,000,000 700,000,000
Common stock, shares, outstanding (in shares) 385,417,665 393,283,720
Common stock, shares, issued (in shares) 385,417,665 393,283,720
[1] Accounts receivable includes amounts with related parties of €1.1 million and €70.8 million at December 31, 2025 and 2024, respectively.
[2] Loans receivable – current includes amounts with related parties of €260.2 million and €0.0 million at December 31, 2025 and 2024, respectively.
[3] Loans receivable – non-current includes amounts with related parties of €1,647.3 million and €1,440.8 million at December 31, 2025 and 2024, respectively
[4] Other assets – current includes amounts with related parties of €323.5 million and €815.8 million at December 31, 2025 and 2024, respectively.
[5] Other assets – non-current includes amounts with related parties of €868.4 million and €599.9 million at December 31, 2025 and 2024, respectively.
[6] Accounts payable includes amounts with related parties of €1,085.8 million and €955.8 million at December 31, 2025 and 2024, respectively.